The UK's energy partner.

Learn more at equinore.

Good morning from the newsroom of the Financial Times.

Today is Friday January 4th, and this is your FT news briefing.

Today, we'll be looking at why markets expect the Federal Reserve to pause the pace of future interest rate rises,

what Bristol-Myers Squibbs 90 billion-dollar takeover of cell gene means for pharma-M&A this year,

and a genetic breakthrough in plant production.

Then the F.T.'s Michael Peel will tell us why EU officials want a tough and scrutiny of Chinese

technology companies.

I'm Amy Keene and here's the news you need to start your debt.

I'm Robin and Wiekelworth. I'm the U.S. Marcus editor at the Financial Times.

On Thursday, global markets fell even lower as Apple's revenue warning really spooked investors

who are already on the edge about where the global economy is heading in 2019. The fact that Apple the biggest company in the world at one point

saying that China's slowdown is even sharper than expected is something that has

frayed already frazzled nerves on Wall Street.

The big fear is how healthy is the global economy and what does that mean for corporate profits?

The US stock market especially has been on a tier

since the financial crisis and now the worry after a very tumultuous December and

a pretty rocky start to 2019 that the big long bull run since 2009 is now finally at an end.

Another concern is the trade war and how that will weigh on China on the US and global economic conditions.

The US government shutdown is exacerbating concerns at a very sensitive time for markets

as well. One of the most notable developments over the past two days has been the total collapse and expectations of what the Federal Reserve will do in 2019.

...